GeneSys Bio
PrivateLast Round
Grant
Jun 1, 2024
Total Funding Raised
$260,700
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GeneSys Bio operates in Healthcare & Life Sciences and is based in Montefiascone. Its latest recorded funding round was a Grant round in June 2024.
GeneSys Bio is a biotechnology company that develops portable, AI-driven molecular diagnostic platforms for the rapid detection of pathogens and antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneSys Bio Comparables
Compare GeneSys Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innotive Diagnostics | 85% | |
| Llusern Scientific | 84% | |
| Detechgene | 83% |
For institutional investors. Book with your work email.
GeneSys Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Accelerator | Jul 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GeneSys Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AC75 Startup Accelerator | Accelerator |
| CDP Venture Capital SGR | Accelerator |
| Lazio Innova | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 202% MoM, reaching 2.4K.
- Jun 19, 2026
Monthly visitors increased 57% MoM.
For institutional investors. Book with your work email.
GeneSys Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneSys Bio's valuation, stock price, and market status.
Is GeneSys Bio a public or private company?
GeneSys Bio is a private company.
What is the current stock price of GeneSys Bio?
GeneSys Bio is a private company, so its shares have no public market price. Caplight tracks GeneSys Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneSys Bio worth (valuation)?
Valuation information for GeneSys Bio is not publicly available.
Can I buy GeneSys Bio stock?
GeneSys Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneSys Bio's last funding round?
GeneSys Bio's most recent funding round was Grant on June 1, 2024.
Who are the main investors in GeneSys Bio?
Key investors in GeneSys Bio include AC75 Startup Accelerator, CDP Venture Capital SGR, Lazio Innova.
Will GeneSys Bio IPO soon?
No public IPO plans have been announced for GeneSys Bio.
How can I track GeneSys Bio secondary market activity?
Caplight tracks bids, offers, and trades in GeneSys Bio's shares on secondary markets.